Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease Recent Helicobacter pylori and NSAIDs are probably the commonest known exogenous factors in the aetiology of peptic ulcer disease. This paper describes the pathogenetic mechanisms common to H pylori and NSAIDs and discusses the possibility of a synergistic relation between them. The importance of such a relation, if present, relates to its potential to provide a new therapeutic approach to the common, but yet unresolved, problem of ulcers induced by NSAIDs.
Effect of NSAIDs and H pylori on gastric acid secretion Because of the widely accepted importance of gastric acid in the pathogenesis of ulcers in general, it was only natural for many workers to investigate the possible effects of NSAIDs and, more recently, H pylorn on acid secretion. NSAIDs (indomethacin and aspirin in particular) were found to increase basal and maximally stimulated gastric acid secretion'3; they seem to bypass the H2 and muscarinic receptors and interact with secretagogues at a locus between the catalytic subunit of adenylate cyclase activation and the proton pump. 4 The potentiation of secretagogue stimulated acid secretion by non-salicylate NSAIDs has also been found to be dependent on calcium. 4 The situation is not so well defined in the case of H pylori. Because of its association with hypergastrinaemia, it was speculated that H pylori could increase the parietal cell mass that is characteristic of patients with duodenal ulcers.5 To date, the evidence for an increase in gastric acid secretion by H pylori has, however, been lacking.56 On the contrary, there is a consensus that acute exposure to H pylon causes hypochlorhydria. 7-" Recent evidence indicates that hypergastrinaemia associated with H pylon might not be directly related to the function of the parietal cells,'2 the number of antral G cells,'3 or to the bacterium's urease activity. 14 It is more likely to be related to local inflammation'"'5 or products of the T lymphocyte such as interleukin-2 and y-interferon. ' Histological and endoscopic abnormalities Active chronic gastritis is the classic histological picture found in association with H pylori in most infected subjects. It is best remembered as the main abnormality seen after the deliberate ingestion of the organisms to fulfil Koch's postulates for the pathogenicity ofHpylori,7 and in epidemic gastritis.9 It is also the commonest histological finding in patients treated with NSAIDs.4' Neutrophilic infiltration, common to most cases ofNSAID and Hpylori gastritis, could be related to the capacity of NSAIDs and H pylori to stimulate the production of platelet activating factor.42 43 As well as its ulcerogenic actions,42 platelet activating factor might be involved in the aggregation and activation of neutrophils," which might subsequently contribute to ulcer formation: neutropenic rats are less likely to develop gastric mucosal injury from indomethacin or naproxen.4445 These interesting findings might not apply, however, to patients with chemical gastritis, another histological abnormality characteristic of chronic NSAID intake.4'" Not unlike bile reflux gastritis in patients with a history of gastroduodenal surgery,47 it is characterised by foveolar hyperplasia, vasodilatation, oedema, lack of inflammatory cells, and the presence of muscle fibres in the lamina propria.41' 9 H pyloni is very rare in cases of chemical gastritis,4' "47 and the histological picture can be found in about 25% of chronic NSAID users.4'46The importance of such an entity stems from the positive correlation between the histological chemical scores and the degree of endoscopic damage: peptic ulcers related to NSAIDs and measuring 5 mm in diameter were found more commonly in patients with chemical gastritis or gastritis associated with H pylori than in those without either ofthese conditions.4' This is in agreement with other studies,505' that found a greater number of gastric ulcers in NSAID patients infected with H pylori compared with patients either taking NSAIDs or infected with Hpylon. The prevalence of NSAID related ulcers in H pylori positive patients has also been found to be twice that in H pylori negative subjects, but the differences were not significant due to the small numbers of patients and ulcers studied. 5253 Graham et al52 found a greater number of submucosal haemorrhages and erosions in H pylori negative NSAID users, unlike the results of another report, which suggested that the presence of H pylon had no influence on the prevalence of such lesions after the acute administration of naproxen or aspirin in healthy volunteers.54 Also, Shallcross et al53 found more duodenal than gastric ulcers in their NSAID patients, which is not typical of NSAID related damage, and could be explained by the fact that they included in their study patients who were able to stop their NSAID within a month before endoscopy. This would in turn raise concern about the suitability of such subjects for analysis and their need for and compliance with NSAID intake, which can determine the extent of peptic damage. A more recent study in asymptomatic NSAID users from the community has found that H pylon infection was not related to the severity of the endoscopic findings, but to higher degrees of gastritis,55 which in the long term might progress to ulceration. 56 The interpretation of the findings related to submucosal haemorrhages or erosions is made difficult by the chronic nature of H pylorn infection, its association with ulcers, and the lack of evidence that such minor lesions can really progress to ulcers. Another possible explanation for the differences in the findings of these studies4' 5055 is the failure to correct for the presence of chemical gastritis, which appears to act as an independent factor, and the use of serological tests of unproved value in patients treated with NSAIDs. Diagnostic titres of H pylont IgG antibodies could still be detected in patients with chemical gastritis, with its high prevalence of NSAID ulcers, despite the failure to confirm the presence of the organisms by culture, histology, or urease activity.5758 Also serology might not be reliable enough in predicting the presence of H pylorn or ulcers in NSAID patients, unlike other categories of patients,59" because: firstly, NSAID ulcers can be completely without symptoms6162; secondly, the specificity of some IgG tests might be low in patients receiving NSAIDs57 58; thirdly, despite the apparent synergistic relation between H pylorn and NSAIDs, the intake of such drugs might be associated with a reduced prevalence of H pylori infection4'157 [63] [64] [65] : this could be due to a direct toxic action, or indirectly related to the increase in acid secretion'" and the interference with the mucus layer2''27 rendering the natural habitat of H pylori organisms unsuitable for their survival.
The virulence ofHpylori strains might also explain some of the differences in the reported rates of ulcer formation. Western blotting analysis of systemic IgG or IgA responses to H pylori has shown the antigenicity of 110-120 kDa, 89 kDa, 61 kDa, 54 kDa, and 31 kDa proteins, although there is substantial variability among subjects.'10 The 120 kDa protein, which is recognised systemically in 83% of H pylon positive subjects, is a surface protein not expressed in some H pylori strains.6" It has been suggested that 120 kDa positive strains have pathogenetic features associated with active gastritis and peptic ulcerations.70 Infection with 120 kDa negative strains might explain why peptic ulceration develops in only a proportion of subjects infected with H pylon. 70 A vaculating cytopathic agent has also been described in some strains ofH pyloni.7' It is not, however, known whether these important findings would apply to patients receiving long term NSAIDs.
Therapeutic considerations
The role of eradicating H pylori in the healing or the prevention of NSAID related peptic ulcers has not been studied. As well as their antibacterial activity, however, agents currently used in the treatment of H pylon infection were previously found to possess properties relevant to the mechansims of NSAID induced mucosal damage. Colloidal bismuth subcitrate was shown to stimulate gastric and duodenal alkaline secretion through a prostaglandin dependent mechanism.72 The same agent was also found to have a protective action against aspirin induced microbleeding, and this protection occurred despite a pronounced suppression of mucosal prostaglandin production.73 Also 
